Yaffe and Aranda's neonatal and pediatric pharmacology :: therapeutic principles in practice /
"Textbook in pediatric pharmacology and provides evidence-based guidelines for safe, effective, and rational drug therapy in newborns, children, and adolescents"--
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Philadelphia :
Wolters Kluwer,
[2021]
|
| Ausgabe: | Fifth edition. |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Zusammenfassung: | "Textbook in pediatric pharmacology and provides evidence-based guidelines for safe, effective, and rational drug therapy in newborns, children, and adolescents"-- |
| Beschreibung: | Revision of: Neonatal and pediatric pharmacology / [edited by] Sumner J. Yaffe, Jacob V. Aranda. c2010. 4th ed. |
| Beschreibung: | 1 online resource : illustrations |
| Bibliographie: | Includes bibliographical references and index. |
| ISBN: | 9781975112493 1975112490 |
Internformat
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | ZDB-4-EBA-on1341396978 | ||
| 003 | OCoLC | ||
| 005 | 20241004212047.0 | ||
| 006 | m o d | ||
| 007 | cr cnu|||unuuu | ||
| 008 | 220819s2021 paua ob 001 0 eng d | ||
| 040 | |a N$T |b eng |e rda |e pn |c N$T |d N$T |d OCLCF |d OCLCQ |d TFW |d FHJ |d OCLCO |d OCLCL | ||
| 020 | |a 9781975112493 |q (electronic bk.) | ||
| 020 | |a 1975112490 |q (electronic bk.) | ||
| 020 | |z 9781975112486 |q hardcover | ||
| 020 | |z 1975112482 |q hardcover | ||
| 035 | |a (OCoLC)1341396978 | ||
| 050 | 4 | |a RJ560 | |
| 060 | 4 | |a WS 366 | |
| 082 | 7 | |a 615.1083 |2 23 | |
| 049 | |a MAIN | ||
| 100 | 1 | |a Aranda, Jacob V., |e author. |0 http://id.loc.gov/authorities/names/n88675618 | |
| 245 | 1 | 0 | |a Yaffe and Aranda's neonatal and pediatric pharmacology : |b therapeutic principles in practice / |c Jacob (Jack) Aranda, MD, PhD, FRCPC, FAAP, Johannes (John) van den Ankerr, MD, PhD, FCP, FAAP. |
| 250 | |a Fifth edition. | ||
| 264 | 1 | |a Philadelphia : |b Wolters Kluwer, |c [2021] | |
| 300 | |a 1 online resource : |b illustrations | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 500 | |a Revision of: Neonatal and pediatric pharmacology / [edited by] Sumner J. Yaffe, Jacob V. Aranda. c2010. 4th ed. | ||
| 504 | |a Includes bibliographical references and index. | ||
| 505 | 0 | 0 | |g Section I: |t General principles. |t Clinical trials involving children: history, rationale, regulatory framework, and technical considerations ; |t Clinical pharmacokinetics in infants and children ; |t Developmental pharmacodynamics, receptor function, and drug actions in newborns and children ; |t Drug absorption, distribution, metabolsim, excretion, and transporters in newborns and children ; |t Pharmacogenetics, pharmacogenomics, and pharmacoproteomics in newborns and children ; |t Ethics of drug research in newborns and children ; |t Precision medicie and therapeutic drug monitoring ; |t Drug formulations for children -- |g Section II: |t Pharmacology in special settings and population: the newborn. |t Role of placenta in drug metabolism and drug transfer ; |t Maternal medications during pregnancy and lactation ; |t Principles of neonatal pharmacology ; |t Renal function and excretion of drugs in the newborn ; |t Neuroprotective drugs and perinatal brain injury ; |t Pharmacologic agents for neonatal hyperbilirubinemia ; |t Pharmacologic treatment of neonatal apnea -- |g Section III: |t Pharmacology in special settings and population. |t Therapeutic applications in pediatric intensive care ; |t Drug therapy in the pediatric emergency department ; |t Topical medications ; |t Ophthalmologic drugs in infants and children -- |g Section IV: |t Antimicrobial pharmacology. |t Penicillins, cephalosporins, and other [beta]-lactams ; |t Glycopeptides, lipoglycopeptides, and lipopeptides ; |t Aminoglycosides ; |t Macrolides, clindamycin, and oxazolidinones ; |t Fluoroquinolones ; |t Sulfonamides, dihydrofolate reductase inhibitors, and dapsone ; |t Tetracyclines, chloramphenicol, and metronidazole ; |t Antimalarials ; |t Anthelminthics drugs in children ; |t Antimycobacterial drugs (mycobacterium tuberculosis and atypical mycobacteria) ; |t Antifungal agents ; |t Antivirals in newborns and children ; |t Pharmacology of antiretroviral drugs in pregnant and breastfeeding women and their newborns -- |g Section V: |t Neuropharmacology. |t Anticonvulsants ; |t Antidepressants and mood stabilizers ; |t Stimulants, ADHD treatments, and antipsychotics ; |t Analgesics and sedatives ; |t Pharmacologic management of neonatal abstinence syndrome ; |t Local anesthetic agents for regional and superficial anesthesia in infants, children and adolescents -- |g Section VI: |t Immunopharmacology, allergy, and inflammation. |t Nonsteroida anti-inflammatory drugs ; |t Antihistamine drugs ; |t Antiasthmatics ; |t Immunosuppressive and immunomodulatory drugs -- |g Section VII: |t Pharmacology of biologic drugs. |t Microbial therapeutics: beyond probiotics ; |t Monoclonal antibiotics ; |t Stem cells ; |t Drugs, lung development, and pulmonary surfactant ; |t Childhood vaccines -- |g Section VIII: |t Cardiorenal drugs. |t Neonatal cardiovascular pharmacology ; |t Antiarrhythmic drugs: disorders of cardiac rhythm and pharmacologic management ; |t Antihypertensive drugs ; |t Diuretics -- |g Section IX: |t Gastrointestinal pharmacology. |t Gastrointestinal drugs ; |t Drugs in inflammatory bowel disease -- |g Section X: |t Endocrine and hematologic pharmacology. |t Glucocorticoids ; |t Insulin and diabetes ; |t Growth hormone ; |t Thyroid hormones ; |t Hematologic agents ; |t Clinical pharmacology of antineoplastic drugs -- |g Section XI: |t Nutritional pharmacology, pharmacotoxidromes, adverse drug reactions, and interactions. |t Nutrient supplements ; |t Herbal drugs in children ; |t Pediatric poisonings and antidotes ; |t Adverse drug reactions in newborns and children ; |t Medication errors in children ; |t Drug interactions in newborns and children -- |g Appendix A1: |t Neonatal drug formulary -- |g Appendix A2: |t Pediatric drug formulary. |
| 520 | |a "Textbook in pediatric pharmacology and provides evidence-based guidelines for safe, effective, and rational drug therapy in newborns, children, and adolescents"-- |c Provided by publisher. | ||
| 588 | 0 | |a Online resource; title from PDF title page (EBSCOhost platform, viewed March 31, 2023). | |
| 650 | 0 | |a Pediatric pharmacology. |0 http://id.loc.gov/authorities/subjects/sh85099170 | |
| 650 | 0 | |a Children |x Diseases |x Chemotherapy. |0 http://id.loc.gov/authorities/subjects/sh85023435 | |
| 650 | 0 | |a Chemotherapy. |0 http://id.loc.gov/authorities/subjects/sh85023041 | |
| 650 | 0 | |a Children. |0 http://id.loc.gov/authorities/subjects/sh85023418 | |
| 650 | 0 | |a Infants. |0 http://id.loc.gov/authorities/subjects/sh85066022 | |
| 650 | 0 | |a Drugs |x Dosage. |0 http://id.loc.gov/authorities/subjects/sh85039725 | |
| 650 | 2 | |a Drug Therapy |0 https://id.nlm.nih.gov/mesh/D004358 | |
| 650 | 2 | |a Child |0 https://id.nlm.nih.gov/mesh/D002648 | |
| 650 | 2 | |a Infant |0 https://id.nlm.nih.gov/mesh/D007223 | |
| 650 | 2 | |a Pharmaceutical Preparations |x administration & dosage |0 https://id.nlm.nih.gov/mesh/D004364Q000008 | |
| 650 | 2 | |a Pharmacological Phenomena |0 https://id.nlm.nih.gov/mesh/D000069437 | |
| 650 | 6 | |a Pharmacologie pédiatrique. | |
| 650 | 6 | |a Enfants |x Maladies |x Chimiothérapie. | |
| 650 | 6 | |a Chimiothérapie. | |
| 650 | 6 | |a Enfants. | |
| 650 | 6 | |a Nourrissons. | |
| 650 | 6 | |a Posologie. | |
| 650 | 7 | |a children (people by age group) |2 aat | |
| 650 | 7 | |a infants. |2 aat | |
| 650 | 7 | |a Children |x Diseases |x Chemotherapy |2 fast | |
| 650 | 7 | |a Pediatric pharmacology |2 fast | |
| 700 | 1 | |a Van den Anker, John N., |e author. |0 http://id.loc.gov/authorities/names/n2006184352 | |
| 758 | |i has work: |a Yaffe and Aranda's neonatal and pediatric pharmacology (Text) |1 https://id.oclc.org/worldcat/entity/E39PCFGPK8YvcYmgQXgYtjdXq3 |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 776 | 0 | 8 | |i Print version: |a Aranda, Jacob V. |t Yaffe and Aranda's neonatal and pediatric pharmacology. |b Fifth edition. |d Philadelphia : Wolters Kluwer, [2021] |z 9781975112486 |w (DLC) 2020028621 |w (OCoLC)1162186883 |
| 856 | 4 | 0 | |l FWS01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=3241830 |3 Volltext |
| 938 | |a EBSCOhost |b EBSC |n 3241830 | ||
| 994 | |a 92 |b GEBAY | ||
| 912 | |a ZDB-4-EBA | ||
| 049 | |a DE-863 | ||
Datensatz im Suchindex
| DE-BY-FWS_katkey | ZDB-4-EBA-on1341396978 |
|---|---|
| _version_ | 1816882563942187008 |
| adam_text | |
| any_adam_object | |
| author | Aranda, Jacob V. Van den Anker, John N. |
| author_GND | http://id.loc.gov/authorities/names/n88675618 http://id.loc.gov/authorities/names/n2006184352 |
| author_facet | Aranda, Jacob V. Van den Anker, John N. |
| author_role | aut aut |
| author_sort | Aranda, Jacob V. |
| author_variant | j v a jv jva d a j n v dajn dajnv |
| building | Verbundindex |
| bvnumber | localFWS |
| callnumber-first | R - Medicine |
| callnumber-label | RJ560 |
| callnumber-raw | RJ560 |
| callnumber-search | RJ560 |
| callnumber-sort | RJ 3560 |
| callnumber-subject | RJ - Pediatrics |
| collection | ZDB-4-EBA |
| contents | General principles. Clinical trials involving children: history, rationale, regulatory framework, and technical considerations ; Clinical pharmacokinetics in infants and children ; Developmental pharmacodynamics, receptor function, and drug actions in newborns and children ; Drug absorption, distribution, metabolsim, excretion, and transporters in newborns and children ; Pharmacogenetics, pharmacogenomics, and pharmacoproteomics in newborns and children ; Ethics of drug research in newborns and children ; Precision medicie and therapeutic drug monitoring ; Drug formulations for children -- Pharmacology in special settings and population: the newborn. Role of placenta in drug metabolism and drug transfer ; Maternal medications during pregnancy and lactation ; Principles of neonatal pharmacology ; Renal function and excretion of drugs in the newborn ; Neuroprotective drugs and perinatal brain injury ; Pharmacologic agents for neonatal hyperbilirubinemia ; Pharmacologic treatment of neonatal apnea -- Pharmacology in special settings and population. Therapeutic applications in pediatric intensive care ; Drug therapy in the pediatric emergency department ; Topical medications ; Ophthalmologic drugs in infants and children -- Antimicrobial pharmacology. Penicillins, cephalosporins, and other [beta]-lactams ; Glycopeptides, lipoglycopeptides, and lipopeptides ; Aminoglycosides ; Macrolides, clindamycin, and oxazolidinones ; Fluoroquinolones ; Sulfonamides, dihydrofolate reductase inhibitors, and dapsone ; Tetracyclines, chloramphenicol, and metronidazole ; Antimalarials ; Anthelminthics drugs in children ; Antimycobacterial drugs (mycobacterium tuberculosis and atypical mycobacteria) ; Antifungal agents ; Antivirals in newborns and children ; Pharmacology of antiretroviral drugs in pregnant and breastfeeding women and their newborns -- Neuropharmacology. Anticonvulsants ; Antidepressants and mood stabilizers ; Stimulants, ADHD treatments, and antipsychotics ; Analgesics and sedatives ; Pharmacologic management of neonatal abstinence syndrome ; Local anesthetic agents for regional and superficial anesthesia in infants, children and adolescents -- Immunopharmacology, allergy, and inflammation. Nonsteroida anti-inflammatory drugs ; Antihistamine drugs ; Antiasthmatics ; Immunosuppressive and immunomodulatory drugs -- Pharmacology of biologic drugs. Microbial therapeutics: beyond probiotics ; Monoclonal antibiotics ; Stem cells ; Drugs, lung development, and pulmonary surfactant ; Childhood vaccines -- Cardiorenal drugs. Neonatal cardiovascular pharmacology ; Antiarrhythmic drugs: disorders of cardiac rhythm and pharmacologic management ; Antihypertensive drugs ; Diuretics -- Gastrointestinal pharmacology. Gastrointestinal drugs ; Drugs in inflammatory bowel disease -- Endocrine and hematologic pharmacology. Glucocorticoids ; Insulin and diabetes ; Growth hormone ; Thyroid hormones ; Hematologic agents ; Clinical pharmacology of antineoplastic drugs -- Nutritional pharmacology, pharmacotoxidromes, adverse drug reactions, and interactions. Nutrient supplements ; Herbal drugs in children ; Pediatric poisonings and antidotes ; Adverse drug reactions in newborns and children ; Medication errors in children ; Drug interactions in newborns and children -- Neonatal drug formulary -- Pediatric drug formulary. |
| ctrlnum | (OCoLC)1341396978 |
| dewey-full | 615.1083 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615.1083 |
| dewey-search | 615.1083 |
| dewey-sort | 3615.1083 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| edition | Fifth edition. |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>07228cam a2200697 i 4500</leader><controlfield tag="001">ZDB-4-EBA-on1341396978</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20241004212047.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr cnu|||unuuu</controlfield><controlfield tag="008">220819s2021 paua ob 001 0 eng d</controlfield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">N$T</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="e">pn</subfield><subfield code="c">N$T</subfield><subfield code="d">N$T</subfield><subfield code="d">OCLCF</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">TFW</subfield><subfield code="d">FHJ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCL</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781975112493</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1975112490</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9781975112486</subfield><subfield code="q">hardcover</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">1975112482</subfield><subfield code="q">hardcover</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1341396978</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RJ560</subfield></datafield><datafield tag="060" ind1=" " ind2="4"><subfield code="a">WS 366</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">615.1083</subfield><subfield code="2">23</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Aranda, Jacob V.,</subfield><subfield code="e">author.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n88675618</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Yaffe and Aranda's neonatal and pediatric pharmacology :</subfield><subfield code="b">therapeutic principles in practice /</subfield><subfield code="c">Jacob (Jack) Aranda, MD, PhD, FRCPC, FAAP, Johannes (John) van den Ankerr, MD, PhD, FCP, FAAP.</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">Fifth edition.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Philadelphia :</subfield><subfield code="b">Wolters Kluwer,</subfield><subfield code="c">[2021]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource :</subfield><subfield code="b">illustrations</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Revision of: Neonatal and pediatric pharmacology / [edited by] Sumner J. Yaffe, Jacob V. Aranda. c2010. 4th ed.</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index.</subfield></datafield><datafield tag="505" ind1="0" ind2="0"><subfield code="g">Section I:</subfield><subfield code="t">General principles.</subfield><subfield code="t">Clinical trials involving children: history, rationale, regulatory framework, and technical considerations ;</subfield><subfield code="t">Clinical pharmacokinetics in infants and children ;</subfield><subfield code="t">Developmental pharmacodynamics, receptor function, and drug actions in newborns and children ;</subfield><subfield code="t">Drug absorption, distribution, metabolsim, excretion, and transporters in newborns and children ;</subfield><subfield code="t">Pharmacogenetics, pharmacogenomics, and pharmacoproteomics in newborns and children ;</subfield><subfield code="t">Ethics of drug research in newborns and children ;</subfield><subfield code="t">Precision medicie and therapeutic drug monitoring ;</subfield><subfield code="t">Drug formulations for children --</subfield><subfield code="g">Section II:</subfield><subfield code="t">Pharmacology in special settings and population: the newborn.</subfield><subfield code="t">Role of placenta in drug metabolism and drug transfer ;</subfield><subfield code="t">Maternal medications during pregnancy and lactation ;</subfield><subfield code="t">Principles of neonatal pharmacology ;</subfield><subfield code="t">Renal function and excretion of drugs in the newborn ;</subfield><subfield code="t">Neuroprotective drugs and perinatal brain injury ;</subfield><subfield code="t">Pharmacologic agents for neonatal hyperbilirubinemia ;</subfield><subfield code="t">Pharmacologic treatment of neonatal apnea --</subfield><subfield code="g">Section III:</subfield><subfield code="t">Pharmacology in special settings and population.</subfield><subfield code="t">Therapeutic applications in pediatric intensive care ;</subfield><subfield code="t">Drug therapy in the pediatric emergency department ;</subfield><subfield code="t">Topical medications ;</subfield><subfield code="t">Ophthalmologic drugs in infants and children --</subfield><subfield code="g">Section IV:</subfield><subfield code="t">Antimicrobial pharmacology.</subfield><subfield code="t">Penicillins, cephalosporins, and other [beta]-lactams ;</subfield><subfield code="t">Glycopeptides, lipoglycopeptides, and lipopeptides ;</subfield><subfield code="t">Aminoglycosides ;</subfield><subfield code="t">Macrolides, clindamycin, and oxazolidinones ;</subfield><subfield code="t">Fluoroquinolones ;</subfield><subfield code="t">Sulfonamides, dihydrofolate reductase inhibitors, and dapsone ;</subfield><subfield code="t">Tetracyclines, chloramphenicol, and metronidazole ;</subfield><subfield code="t">Antimalarials ;</subfield><subfield code="t">Anthelminthics drugs in children ;</subfield><subfield code="t">Antimycobacterial drugs (mycobacterium tuberculosis and atypical mycobacteria) ;</subfield><subfield code="t">Antifungal agents ;</subfield><subfield code="t">Antivirals in newborns and children ;</subfield><subfield code="t">Pharmacology of antiretroviral drugs in pregnant and breastfeeding women and their newborns --</subfield><subfield code="g">Section V:</subfield><subfield code="t">Neuropharmacology.</subfield><subfield code="t">Anticonvulsants ;</subfield><subfield code="t">Antidepressants and mood stabilizers ;</subfield><subfield code="t">Stimulants, ADHD treatments, and antipsychotics ;</subfield><subfield code="t">Analgesics and sedatives ;</subfield><subfield code="t">Pharmacologic management of neonatal abstinence syndrome ;</subfield><subfield code="t">Local anesthetic agents for regional and superficial anesthesia in infants, children and adolescents --</subfield><subfield code="g">Section VI:</subfield><subfield code="t">Immunopharmacology, allergy, and inflammation.</subfield><subfield code="t">Nonsteroida anti-inflammatory drugs ;</subfield><subfield code="t">Antihistamine drugs ;</subfield><subfield code="t">Antiasthmatics ;</subfield><subfield code="t">Immunosuppressive and immunomodulatory drugs --</subfield><subfield code="g">Section VII:</subfield><subfield code="t">Pharmacology of biologic drugs.</subfield><subfield code="t">Microbial therapeutics: beyond probiotics ;</subfield><subfield code="t">Monoclonal antibiotics ;</subfield><subfield code="t">Stem cells ;</subfield><subfield code="t">Drugs, lung development, and pulmonary surfactant ;</subfield><subfield code="t">Childhood vaccines --</subfield><subfield code="g">Section VIII:</subfield><subfield code="t">Cardiorenal drugs.</subfield><subfield code="t">Neonatal cardiovascular pharmacology ;</subfield><subfield code="t">Antiarrhythmic drugs: disorders of cardiac rhythm and pharmacologic management ;</subfield><subfield code="t">Antihypertensive drugs ;</subfield><subfield code="t">Diuretics --</subfield><subfield code="g">Section IX:</subfield><subfield code="t">Gastrointestinal pharmacology.</subfield><subfield code="t">Gastrointestinal drugs ;</subfield><subfield code="t">Drugs in inflammatory bowel disease --</subfield><subfield code="g">Section X:</subfield><subfield code="t">Endocrine and hematologic pharmacology.</subfield><subfield code="t">Glucocorticoids ;</subfield><subfield code="t">Insulin and diabetes ;</subfield><subfield code="t">Growth hormone ;</subfield><subfield code="t">Thyroid hormones ;</subfield><subfield code="t">Hematologic agents ;</subfield><subfield code="t">Clinical pharmacology of antineoplastic drugs --</subfield><subfield code="g">Section XI:</subfield><subfield code="t">Nutritional pharmacology, pharmacotoxidromes, adverse drug reactions, and interactions.</subfield><subfield code="t">Nutrient supplements ;</subfield><subfield code="t">Herbal drugs in children ;</subfield><subfield code="t">Pediatric poisonings and antidotes ;</subfield><subfield code="t">Adverse drug reactions in newborns and children ;</subfield><subfield code="t">Medication errors in children ;</subfield><subfield code="t">Drug interactions in newborns and children --</subfield><subfield code="g">Appendix A1:</subfield><subfield code="t">Neonatal drug formulary --</subfield><subfield code="g">Appendix A2:</subfield><subfield code="t">Pediatric drug formulary.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">"Textbook in pediatric pharmacology and provides evidence-based guidelines for safe, effective, and rational drug therapy in newborns, children, and adolescents"--</subfield><subfield code="c">Provided by publisher.</subfield></datafield><datafield tag="588" ind1="0" ind2=" "><subfield code="a">Online resource; title from PDF title page (EBSCOhost platform, viewed March 31, 2023).</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Pediatric pharmacology.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85099170</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Children</subfield><subfield code="x">Diseases</subfield><subfield code="x">Chemotherapy.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85023435</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Chemotherapy.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85023041</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Children.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85023418</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Infants.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85066022</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Drugs</subfield><subfield code="x">Dosage.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85039725</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Drug Therapy</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D004358</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Child</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D002648</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Infant</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D007223</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Pharmaceutical Preparations</subfield><subfield code="x">administration & dosage</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D004364Q000008</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Pharmacological Phenomena</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D000069437</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Pharmacologie pédiatrique.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Enfants</subfield><subfield code="x">Maladies</subfield><subfield code="x">Chimiothérapie.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Chimiothérapie.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Enfants.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Nourrissons.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Posologie.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">children (people by age group)</subfield><subfield code="2">aat</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">infants.</subfield><subfield code="2">aat</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Children</subfield><subfield code="x">Diseases</subfield><subfield code="x">Chemotherapy</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pediatric pharmacology</subfield><subfield code="2">fast</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Van den Anker, John N.,</subfield><subfield code="e">author.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n2006184352</subfield></datafield><datafield tag="758" ind1=" " ind2=" "><subfield code="i">has work:</subfield><subfield code="a">Yaffe and Aranda's neonatal and pediatric pharmacology (Text)</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PCFGPK8YvcYmgQXgYtjdXq3</subfield><subfield code="4">https://id.oclc.org/worldcat/ontology/hasWork</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="a">Aranda, Jacob V.</subfield><subfield code="t">Yaffe and Aranda's neonatal and pediatric pharmacology.</subfield><subfield code="b">Fifth edition.</subfield><subfield code="d">Philadelphia : Wolters Kluwer, [2021]</subfield><subfield code="z">9781975112486</subfield><subfield code="w">(DLC) 2020028621</subfield><subfield code="w">(OCoLC)1162186883</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=3241830</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">3241830</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
| id | ZDB-4-EBA-on1341396978 |
| illustrated | Illustrated |
| indexdate | 2024-11-27T13:30:37Z |
| institution | BVB |
| isbn | 9781975112493 1975112490 |
| language | English |
| oclc_num | 1341396978 |
| open_access_boolean | |
| owner | MAIN DE-863 DE-BY-FWS |
| owner_facet | MAIN DE-863 DE-BY-FWS |
| physical | 1 online resource : illustrations |
| psigel | ZDB-4-EBA |
| publishDate | 2021 |
| publishDateSearch | 2021 |
| publishDateSort | 2021 |
| publisher | Wolters Kluwer, |
| record_format | marc |
| spelling | Aranda, Jacob V., author. http://id.loc.gov/authorities/names/n88675618 Yaffe and Aranda's neonatal and pediatric pharmacology : therapeutic principles in practice / Jacob (Jack) Aranda, MD, PhD, FRCPC, FAAP, Johannes (John) van den Ankerr, MD, PhD, FCP, FAAP. Fifth edition. Philadelphia : Wolters Kluwer, [2021] 1 online resource : illustrations text txt rdacontent computer c rdamedia online resource cr rdacarrier Revision of: Neonatal and pediatric pharmacology / [edited by] Sumner J. Yaffe, Jacob V. Aranda. c2010. 4th ed. Includes bibliographical references and index. Section I: General principles. Clinical trials involving children: history, rationale, regulatory framework, and technical considerations ; Clinical pharmacokinetics in infants and children ; Developmental pharmacodynamics, receptor function, and drug actions in newborns and children ; Drug absorption, distribution, metabolsim, excretion, and transporters in newborns and children ; Pharmacogenetics, pharmacogenomics, and pharmacoproteomics in newborns and children ; Ethics of drug research in newborns and children ; Precision medicie and therapeutic drug monitoring ; Drug formulations for children -- Section II: Pharmacology in special settings and population: the newborn. Role of placenta in drug metabolism and drug transfer ; Maternal medications during pregnancy and lactation ; Principles of neonatal pharmacology ; Renal function and excretion of drugs in the newborn ; Neuroprotective drugs and perinatal brain injury ; Pharmacologic agents for neonatal hyperbilirubinemia ; Pharmacologic treatment of neonatal apnea -- Section III: Pharmacology in special settings and population. Therapeutic applications in pediatric intensive care ; Drug therapy in the pediatric emergency department ; Topical medications ; Ophthalmologic drugs in infants and children -- Section IV: Antimicrobial pharmacology. Penicillins, cephalosporins, and other [beta]-lactams ; Glycopeptides, lipoglycopeptides, and lipopeptides ; Aminoglycosides ; Macrolides, clindamycin, and oxazolidinones ; Fluoroquinolones ; Sulfonamides, dihydrofolate reductase inhibitors, and dapsone ; Tetracyclines, chloramphenicol, and metronidazole ; Antimalarials ; Anthelminthics drugs in children ; Antimycobacterial drugs (mycobacterium tuberculosis and atypical mycobacteria) ; Antifungal agents ; Antivirals in newborns and children ; Pharmacology of antiretroviral drugs in pregnant and breastfeeding women and their newborns -- Section V: Neuropharmacology. Anticonvulsants ; Antidepressants and mood stabilizers ; Stimulants, ADHD treatments, and antipsychotics ; Analgesics and sedatives ; Pharmacologic management of neonatal abstinence syndrome ; Local anesthetic agents for regional and superficial anesthesia in infants, children and adolescents -- Section VI: Immunopharmacology, allergy, and inflammation. Nonsteroida anti-inflammatory drugs ; Antihistamine drugs ; Antiasthmatics ; Immunosuppressive and immunomodulatory drugs -- Section VII: Pharmacology of biologic drugs. Microbial therapeutics: beyond probiotics ; Monoclonal antibiotics ; Stem cells ; Drugs, lung development, and pulmonary surfactant ; Childhood vaccines -- Section VIII: Cardiorenal drugs. Neonatal cardiovascular pharmacology ; Antiarrhythmic drugs: disorders of cardiac rhythm and pharmacologic management ; Antihypertensive drugs ; Diuretics -- Section IX: Gastrointestinal pharmacology. Gastrointestinal drugs ; Drugs in inflammatory bowel disease -- Section X: Endocrine and hematologic pharmacology. Glucocorticoids ; Insulin and diabetes ; Growth hormone ; Thyroid hormones ; Hematologic agents ; Clinical pharmacology of antineoplastic drugs -- Section XI: Nutritional pharmacology, pharmacotoxidromes, adverse drug reactions, and interactions. Nutrient supplements ; Herbal drugs in children ; Pediatric poisonings and antidotes ; Adverse drug reactions in newborns and children ; Medication errors in children ; Drug interactions in newborns and children -- Appendix A1: Neonatal drug formulary -- Appendix A2: Pediatric drug formulary. "Textbook in pediatric pharmacology and provides evidence-based guidelines for safe, effective, and rational drug therapy in newborns, children, and adolescents"-- Provided by publisher. Online resource; title from PDF title page (EBSCOhost platform, viewed March 31, 2023). Pediatric pharmacology. http://id.loc.gov/authorities/subjects/sh85099170 Children Diseases Chemotherapy. http://id.loc.gov/authorities/subjects/sh85023435 Chemotherapy. http://id.loc.gov/authorities/subjects/sh85023041 Children. http://id.loc.gov/authorities/subjects/sh85023418 Infants. http://id.loc.gov/authorities/subjects/sh85066022 Drugs Dosage. http://id.loc.gov/authorities/subjects/sh85039725 Drug Therapy https://id.nlm.nih.gov/mesh/D004358 Child https://id.nlm.nih.gov/mesh/D002648 Infant https://id.nlm.nih.gov/mesh/D007223 Pharmaceutical Preparations administration & dosage https://id.nlm.nih.gov/mesh/D004364Q000008 Pharmacological Phenomena https://id.nlm.nih.gov/mesh/D000069437 Pharmacologie pédiatrique. Enfants Maladies Chimiothérapie. Chimiothérapie. Enfants. Nourrissons. Posologie. children (people by age group) aat infants. aat Children Diseases Chemotherapy fast Pediatric pharmacology fast Van den Anker, John N., author. http://id.loc.gov/authorities/names/n2006184352 has work: Yaffe and Aranda's neonatal and pediatric pharmacology (Text) https://id.oclc.org/worldcat/entity/E39PCFGPK8YvcYmgQXgYtjdXq3 https://id.oclc.org/worldcat/ontology/hasWork Print version: Aranda, Jacob V. Yaffe and Aranda's neonatal and pediatric pharmacology. Fifth edition. Philadelphia : Wolters Kluwer, [2021] 9781975112486 (DLC) 2020028621 (OCoLC)1162186883 FWS01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=3241830 Volltext |
| spellingShingle | Aranda, Jacob V. Van den Anker, John N. Yaffe and Aranda's neonatal and pediatric pharmacology : therapeutic principles in practice / General principles. Clinical trials involving children: history, rationale, regulatory framework, and technical considerations ; Clinical pharmacokinetics in infants and children ; Developmental pharmacodynamics, receptor function, and drug actions in newborns and children ; Drug absorption, distribution, metabolsim, excretion, and transporters in newborns and children ; Pharmacogenetics, pharmacogenomics, and pharmacoproteomics in newborns and children ; Ethics of drug research in newborns and children ; Precision medicie and therapeutic drug monitoring ; Drug formulations for children -- Pharmacology in special settings and population: the newborn. Role of placenta in drug metabolism and drug transfer ; Maternal medications during pregnancy and lactation ; Principles of neonatal pharmacology ; Renal function and excretion of drugs in the newborn ; Neuroprotective drugs and perinatal brain injury ; Pharmacologic agents for neonatal hyperbilirubinemia ; Pharmacologic treatment of neonatal apnea -- Pharmacology in special settings and population. Therapeutic applications in pediatric intensive care ; Drug therapy in the pediatric emergency department ; Topical medications ; Ophthalmologic drugs in infants and children -- Antimicrobial pharmacology. Penicillins, cephalosporins, and other [beta]-lactams ; Glycopeptides, lipoglycopeptides, and lipopeptides ; Aminoglycosides ; Macrolides, clindamycin, and oxazolidinones ; Fluoroquinolones ; Sulfonamides, dihydrofolate reductase inhibitors, and dapsone ; Tetracyclines, chloramphenicol, and metronidazole ; Antimalarials ; Anthelminthics drugs in children ; Antimycobacterial drugs (mycobacterium tuberculosis and atypical mycobacteria) ; Antifungal agents ; Antivirals in newborns and children ; Pharmacology of antiretroviral drugs in pregnant and breastfeeding women and their newborns -- Neuropharmacology. Anticonvulsants ; Antidepressants and mood stabilizers ; Stimulants, ADHD treatments, and antipsychotics ; Analgesics and sedatives ; Pharmacologic management of neonatal abstinence syndrome ; Local anesthetic agents for regional and superficial anesthesia in infants, children and adolescents -- Immunopharmacology, allergy, and inflammation. Nonsteroida anti-inflammatory drugs ; Antihistamine drugs ; Antiasthmatics ; Immunosuppressive and immunomodulatory drugs -- Pharmacology of biologic drugs. Microbial therapeutics: beyond probiotics ; Monoclonal antibiotics ; Stem cells ; Drugs, lung development, and pulmonary surfactant ; Childhood vaccines -- Cardiorenal drugs. Neonatal cardiovascular pharmacology ; Antiarrhythmic drugs: disorders of cardiac rhythm and pharmacologic management ; Antihypertensive drugs ; Diuretics -- Gastrointestinal pharmacology. Gastrointestinal drugs ; Drugs in inflammatory bowel disease -- Endocrine and hematologic pharmacology. Glucocorticoids ; Insulin and diabetes ; Growth hormone ; Thyroid hormones ; Hematologic agents ; Clinical pharmacology of antineoplastic drugs -- Nutritional pharmacology, pharmacotoxidromes, adverse drug reactions, and interactions. Nutrient supplements ; Herbal drugs in children ; Pediatric poisonings and antidotes ; Adverse drug reactions in newborns and children ; Medication errors in children ; Drug interactions in newborns and children -- Neonatal drug formulary -- Pediatric drug formulary. Pediatric pharmacology. http://id.loc.gov/authorities/subjects/sh85099170 Children Diseases Chemotherapy. http://id.loc.gov/authorities/subjects/sh85023435 Chemotherapy. http://id.loc.gov/authorities/subjects/sh85023041 Children. http://id.loc.gov/authorities/subjects/sh85023418 Infants. http://id.loc.gov/authorities/subjects/sh85066022 Drugs Dosage. http://id.loc.gov/authorities/subjects/sh85039725 Drug Therapy https://id.nlm.nih.gov/mesh/D004358 Child https://id.nlm.nih.gov/mesh/D002648 Infant https://id.nlm.nih.gov/mesh/D007223 Pharmaceutical Preparations administration & dosage https://id.nlm.nih.gov/mesh/D004364Q000008 Pharmacological Phenomena https://id.nlm.nih.gov/mesh/D000069437 Pharmacologie pédiatrique. Enfants Maladies Chimiothérapie. Chimiothérapie. Enfants. Nourrissons. Posologie. children (people by age group) aat infants. aat Children Diseases Chemotherapy fast Pediatric pharmacology fast |
| subject_GND | http://id.loc.gov/authorities/subjects/sh85099170 http://id.loc.gov/authorities/subjects/sh85023435 http://id.loc.gov/authorities/subjects/sh85023041 http://id.loc.gov/authorities/subjects/sh85023418 http://id.loc.gov/authorities/subjects/sh85066022 http://id.loc.gov/authorities/subjects/sh85039725 https://id.nlm.nih.gov/mesh/D004358 https://id.nlm.nih.gov/mesh/D002648 https://id.nlm.nih.gov/mesh/D007223 https://id.nlm.nih.gov/mesh/D004364Q000008 https://id.nlm.nih.gov/mesh/D000069437 |
| title | Yaffe and Aranda's neonatal and pediatric pharmacology : therapeutic principles in practice / |
| title_alt | General principles. Clinical trials involving children: history, rationale, regulatory framework, and technical considerations ; Clinical pharmacokinetics in infants and children ; Developmental pharmacodynamics, receptor function, and drug actions in newborns and children ; Drug absorption, distribution, metabolsim, excretion, and transporters in newborns and children ; Pharmacogenetics, pharmacogenomics, and pharmacoproteomics in newborns and children ; Ethics of drug research in newborns and children ; Precision medicie and therapeutic drug monitoring ; Drug formulations for children -- Pharmacology in special settings and population: the newborn. Role of placenta in drug metabolism and drug transfer ; Maternal medications during pregnancy and lactation ; Principles of neonatal pharmacology ; Renal function and excretion of drugs in the newborn ; Neuroprotective drugs and perinatal brain injury ; Pharmacologic agents for neonatal hyperbilirubinemia ; Pharmacologic treatment of neonatal apnea -- Pharmacology in special settings and population. Therapeutic applications in pediatric intensive care ; Drug therapy in the pediatric emergency department ; Topical medications ; Ophthalmologic drugs in infants and children -- Antimicrobial pharmacology. Penicillins, cephalosporins, and other [beta]-lactams ; Glycopeptides, lipoglycopeptides, and lipopeptides ; Aminoglycosides ; Macrolides, clindamycin, and oxazolidinones ; Fluoroquinolones ; Sulfonamides, dihydrofolate reductase inhibitors, and dapsone ; Tetracyclines, chloramphenicol, and metronidazole ; Antimalarials ; Anthelminthics drugs in children ; Antimycobacterial drugs (mycobacterium tuberculosis and atypical mycobacteria) ; Antifungal agents ; Antivirals in newborns and children ; Pharmacology of antiretroviral drugs in pregnant and breastfeeding women and their newborns -- Neuropharmacology. Anticonvulsants ; Antidepressants and mood stabilizers ; Stimulants, ADHD treatments, and antipsychotics ; Analgesics and sedatives ; Pharmacologic management of neonatal abstinence syndrome ; Local anesthetic agents for regional and superficial anesthesia in infants, children and adolescents -- Immunopharmacology, allergy, and inflammation. Nonsteroida anti-inflammatory drugs ; Antihistamine drugs ; Antiasthmatics ; Immunosuppressive and immunomodulatory drugs -- Pharmacology of biologic drugs. Microbial therapeutics: beyond probiotics ; Monoclonal antibiotics ; Stem cells ; Drugs, lung development, and pulmonary surfactant ; Childhood vaccines -- Cardiorenal drugs. Neonatal cardiovascular pharmacology ; Antiarrhythmic drugs: disorders of cardiac rhythm and pharmacologic management ; Antihypertensive drugs ; Diuretics -- Gastrointestinal pharmacology. Gastrointestinal drugs ; Drugs in inflammatory bowel disease -- Endocrine and hematologic pharmacology. Glucocorticoids ; Insulin and diabetes ; Growth hormone ; Thyroid hormones ; Hematologic agents ; Clinical pharmacology of antineoplastic drugs -- Nutritional pharmacology, pharmacotoxidromes, adverse drug reactions, and interactions. Nutrient supplements ; Herbal drugs in children ; Pediatric poisonings and antidotes ; Adverse drug reactions in newborns and children ; Medication errors in children ; Drug interactions in newborns and children -- Neonatal drug formulary -- Pediatric drug formulary. |
| title_auth | Yaffe and Aranda's neonatal and pediatric pharmacology : therapeutic principles in practice / |
| title_exact_search | Yaffe and Aranda's neonatal and pediatric pharmacology : therapeutic principles in practice / |
| title_full | Yaffe and Aranda's neonatal and pediatric pharmacology : therapeutic principles in practice / Jacob (Jack) Aranda, MD, PhD, FRCPC, FAAP, Johannes (John) van den Ankerr, MD, PhD, FCP, FAAP. |
| title_fullStr | Yaffe and Aranda's neonatal and pediatric pharmacology : therapeutic principles in practice / Jacob (Jack) Aranda, MD, PhD, FRCPC, FAAP, Johannes (John) van den Ankerr, MD, PhD, FCP, FAAP. |
| title_full_unstemmed | Yaffe and Aranda's neonatal and pediatric pharmacology : therapeutic principles in practice / Jacob (Jack) Aranda, MD, PhD, FRCPC, FAAP, Johannes (John) van den Ankerr, MD, PhD, FCP, FAAP. |
| title_short | Yaffe and Aranda's neonatal and pediatric pharmacology : |
| title_sort | yaffe and aranda s neonatal and pediatric pharmacology therapeutic principles in practice |
| title_sub | therapeutic principles in practice / |
| topic | Pediatric pharmacology. http://id.loc.gov/authorities/subjects/sh85099170 Children Diseases Chemotherapy. http://id.loc.gov/authorities/subjects/sh85023435 Chemotherapy. http://id.loc.gov/authorities/subjects/sh85023041 Children. http://id.loc.gov/authorities/subjects/sh85023418 Infants. http://id.loc.gov/authorities/subjects/sh85066022 Drugs Dosage. http://id.loc.gov/authorities/subjects/sh85039725 Drug Therapy https://id.nlm.nih.gov/mesh/D004358 Child https://id.nlm.nih.gov/mesh/D002648 Infant https://id.nlm.nih.gov/mesh/D007223 Pharmaceutical Preparations administration & dosage https://id.nlm.nih.gov/mesh/D004364Q000008 Pharmacological Phenomena https://id.nlm.nih.gov/mesh/D000069437 Pharmacologie pédiatrique. Enfants Maladies Chimiothérapie. Chimiothérapie. Enfants. Nourrissons. Posologie. children (people by age group) aat infants. aat Children Diseases Chemotherapy fast Pediatric pharmacology fast |
| topic_facet | Pediatric pharmacology. Children Diseases Chemotherapy. Chemotherapy. Children. Infants. Drugs Dosage. Drug Therapy Child Infant Pharmaceutical Preparations administration & dosage Pharmacological Phenomena Pharmacologie pédiatrique. Enfants Maladies Chimiothérapie. Chimiothérapie. Enfants. Nourrissons. Posologie. children (people by age group) infants. Children Diseases Chemotherapy Pediatric pharmacology |
| url | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=3241830 |
| work_keys_str_mv | AT arandajacobv yaffeandarandasneonatalandpediatricpharmacologytherapeuticprinciplesinpractice AT vandenankerjohnn yaffeandarandasneonatalandpediatricpharmacologytherapeuticprinciplesinpractice |